Related Experiment Video
Updated: Jul 11, 2026

Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
Functional defecation disorders in children: PACCT criteria versus Rome II criteria
Gabriella Boccia1, Francesco Manguso, Paola Coccorullo
1Department of Pediatrics, University of Federico II, Naples, Italy.
Insights
The Paris Consensus on Childhood Constipation Terminology (PACCT) criteria are more applicable for diagnosing pediatric functional defecation disorders (FDDs) than Rome II criteria. Key symptoms like straining and pebble-like stools should inform future diagnostic revisions.
Area of Science:
- Pediatric Gastroenterology
- Clinical Diagnostics
- Functional Gastrointestinal Disorders
Background:
- Pediatric functional defecation disorders (FDDs) require precise diagnostic criteria for effective management.
- Existing criteria, such as Rome II, may have limitations in capturing the full spectrum of FDDs in children.
- The Paris Consensus on Childhood Constipation Terminology (PACCT) offers a newer framework for FDD diagnosis.
Purpose of the Study:
- To compare the clinical validity and applicability of the PACCT criteria against the Rome II criteria for diagnosing FDDs in children.
- To assess the diagnostic yield of each criterion set in a cohort of referred pediatric patients.
Main Methods:
- A prospective longitudinal study enrolled 128 children (infancy to 17 years) with chronic constipation referred to a tertiary center.
- The Questionnaire on Pediatric Gastrointestinal Symptoms (QPGS) was utilized for diagnosing FDDs in different age groups.
- Diagnostic concordance was evaluated using Cohen's kappa test.
Main Results:
- Functional defecation disorders were diagnosed significantly more often using PACCT (88.9%) compared to Rome II criteria (47.6%) (P = .001).
- Poor agreement was observed between the two criteria sets (Cohen's kappa = .173), indicating they identify different patient populations.
- Scybalous, pebble-like stools and defecation with straining were the most prevalent symptoms (80%).
Conclusions:
- The PACCT criteria demonstrate superior applicability for diagnosing FDDs in pediatric populations compared to Rome II.
- The significant discrepancies highlight that these criteria do not identify the same patient cohorts.
- Symptoms such as defecation with straining, scybalous stools, and painful defecation are highly prevalent and warrant consideration in revised diagnostic criteria.
Objectives:
To evaluate the clinical validity and applicability of the Paris Consensus on Childhood Constipation Terminology (PACCT) versus the Rome II criteria for pediatric functional defecation disorders (FDDs).
Study Design:
Children from infancy to 17 years who had been referred to a tertiary center for chronic constipation were recruited for the study. A prospective longitudinal design was used. The Questionnaire on Pediatric Gastrointestinal Symptoms (QPGS) for parents of children age 0 to 4 and 4 to 17 years and for children age 10 to 17 years was used for diagnosis of FDDs.
Results:
Children (n = 128; mean age, 67.2 months; 62 males) were screened consecutively. FDDs were diagnosed significantly more often by PACCT than by the Rome II criteria (112 [88.9%] vs 60 [47.6%]; P = .001). The agreement Cohen's kappa test showed kappa = .173. A statistically significant difference was reported between Rome II and PACCT in the 4- to 17-year-old group (P = .001). Scybalous, pebble-like stools and defecation with straining were the main symptoms reported (80%), followed by painful defecation (66%).
Conclusions:
The PACCT criteria show greater applicability than the Rome II criteria for FDDs. The poor agreement implies that they do not identify the same types of patients. Because such a high percentage of constipated children reported the symptoms of defecation with straining, scybalous pebble-like stools, and painful defecation, including these symptoms in any revised criteria should be taken into consideration.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Oppositional Defiant Disorder
Diagnostic Criteria and...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Psychosexual Stages of Personality: Anal
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
